Hepatitis B immune globulin. An immune globulin shot which allows patients have short-term protection from hepatitis B. It is commonly used when individuals travel to foreign countries when a vaccination program cannot be completely prior to travel.
Hepatitis B Immune Globulin. Given as a shot, HBIG contains antibodies to hepatitis B virus; it offers prompt protection that lasts up to three months, and is often used if an unvaccinated individual is exposed to hepatitis B.
Hepatitis B Immune Globulin. is a vaccine used for prevention of Hepatitis B infection.
Hepatitis B immune globulin, which contains antibodies to hepatitis B virus and offers prompt but short lived protection.
Hepatitis B Immune Globulin. A product available for prophylaxis against hepatitis B virus infection. HBIG is prepared from plasma containing high titers of anti-HBs and provides short-term protection (three to six months).
Hepatitis B Immune Globulin. A medication that is given as a “post-exposure†treatment to prevent hepatitis B. This means that HBIG is given after a person has been exposed to potentially infected blood or infected bodily fluids, which can include but is not limited to - contact with blood or through a needlestick, infants born to infected women, and through sexual contact or close household contact with an infected person. HBIG is often used as a post-liver transplant treatment.
Hepatitis B Immune Globulin. A medication given after a person is exposed to blood or bodily fluids that might be infected with hepatitis B virus. It helps stop infection before it takes hold.